Dave Muoio
The proposal would fully fund telehealth services and devices for eligible healthcare providers, although some aren't pleased with its exclusion of for-profit hospitals.
The AI company now has a presence among more than 500 U.S. hospitals.
The company is also adding more content to its Fitbit Premium subscription service.
Also: Providence supporting COVID-19 patients at home with Xealth and Twistle; Lief Therapeutics incorporates DrChrono's Open API.
Both efforts are employing popular consumer wearables and health trackers to spot potential cases of COVID-19 or other viral diseases as they begin.
Dr. Yuri Maricich, chief medical officer at Pear Therapeutics, speaks on his company's experience bringing a digital therapeutic product through the regulator's experimental program for health software.
Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces.
The Auto Ejection Fraction Tool and the Auto Bladder Volume Tool both employed AI to help Butterfly iQ users more easily evaluate the patient's condition.
The Series A raise comes just a few months after the company raised $3 million in seed funding.
Also: Healthcare analytics company Apixio picks up a new VP of solutions; Eagle Telemedicine hires on a healthcare-system vet as SVP of operations.